
No. of Pages: 137 | Report Code: BMIRE00031474 | Category: Life Sciences
No. of Pages: 137 | Report Code: BMIRE00031474 | Category: Life Sciences
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Cell and Gene Therapy Market Landscape
4.1 Overview
4.2 PEST Analysis
5. South & Central America Cell and Gene Therapy Market - Key Market Dynamics
5.1 Cell and Gene Therapy Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Increase in Number of Approval of Cell and Gene Therapies
5.2.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing
5.3 Market Restraints
5.3.1 High Cost of Cell and Gene Therapy Manufacturing
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Companies
5.5 Future Trends
5.5.1 Automation of Cell and Gene Therapy Manufacturing Services
5.6 Impact of Drivers and Restraints:
6. Cell and Gene Therapy Market -South & Central America Market Analysis
6.1 Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
6.2 Cell and Gene Therapy Market Forecast Analysis
7. South & Central America Cell and Gene Therapy Market Analysis - by Type
7.1 Cell Therapy
7.1.1 Overview
7.1.2 Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Gene Therapy
7.2.1 Overview
7.2.2 Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8. South & Central America Cell and Gene Therapy Market Analysis - by Services
8.1 Process Development
8.1.1 Overview
8.1.2 Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.2 cGMP Manufacturing
8.2.1 Overview
8.2.2 cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Regulatory Services
8.3.1 Overview
8.3.2 Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Bioassay Services
8.4.1 Overview
8.4.2 Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
9. South & Central America Cell and Gene Therapy Market Analysis - by Scale
9.1 Pre-Commercial/R&D Manufacturing
9.1.1 Overview
9.1.2 Pre-Commercial/R&D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Commercial Scale Manufacturing
9.2.1 Overview
9.2.2 Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
10. South & Central America Cell and Gene Therapy Market Analysis - by Service Providers
10.1 CDMOs
10.1.1 Overview
10.1.2 CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
10.2 CMOs
10.2.1 Overview
10.2.2 CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11. South & Central America Cell and Gene Therapy Market Analysis - by End User
11.1 Contract Research Organizations
11.1.1 Overview
11.1.2 Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Pharmaceutical and Biopharmaceutical Companies
11.2.1 Overview
11.2.2 Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Academic and Research Institutes
11.3.1 Overview
11.3.2 Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12. Cell and Gene Therapy Market - Country Analysis
12.1 South and Central America Cell and Gene Therapy Market, by Key Countries - Revenue (2023) (US$ Million)
12.1.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.1.1.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.1.1.2 Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.2.1 Brazil: Cell and Gene Therapy Market Breakdown, by Type
12.1.1.2.1.1 Brazil: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.1.1.2.1.2 Brazil: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.1.1.2.2 Brazil: Cell and Gene Therapy Market Breakdown, by Services
12.1.1.2.3 Brazil: Cell and Gene Therapy Market Breakdown, by Scale
12.1.1.2.4 Brazil: Cell and Gene Therapy Market Breakdown, by Service Providers
12.1.1.2.5 Brazil: Cell and Gene Therapy Market Breakdown, by End User
12.1.1.3 Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.3.1 Argentina: Cell and Gene Therapy Market Breakdown, by Type
12.1.1.3.1.1 Argentina: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.1.1.3.1.2 Argentina: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.1.1.3.2 Argentina: Cell and Gene Therapy Market Breakdown, by Services
12.1.1.3.3 Argentina: Cell and Gene Therapy Market Breakdown, by Scale
12.1.1.3.4 Argentina: Cell and Gene Therapy Market Breakdown, by Service Providers
12.1.1.3.5 Argentina: Cell and Gene Therapy Market Breakdown, by End User
12.1.1.4 Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.4.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Type
12.1.1.4.1.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.1.1.4.1.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.1.1.4.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Services
12.1.1.4.3 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Scale
12.1.1.4.4 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers
12.1.1.4.5 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in Cell and Gene Therapy Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Thermo Fisher Scientific Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Merck KGaA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Charles River Laboratories International Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Lonza Group AG
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Takara Bio Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 FUJIFILM Holdings Corp
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 F. Hoffmann-La Roche Ltd
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Catalent Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Lotte Corp
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
List of Tables
Table 1. Cell and Gene Therapy Market Segmentation
Table 2. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 4. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Cell Therapy
Table 5. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Gene Therapy
Table 6. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Services
Table 7. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Scale
Table 8. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Service Providers
Table 9. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 10. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 11. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 12. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 13. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 14. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 15. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 16. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 17. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 18. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 19. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 20. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 21. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 22. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 23. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 24. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 25. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 26. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 27. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 28. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 29. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 30. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 31. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 32. Recent Organic Growth Strategies in Cell and Gene Therapy Market
Table 33. Recent Inorganic Growth Strategies in the Cell and Gene Therapy Market
Table 34. Glossary of Terms
List of Figures
Figure 1. Cell and Gene Therapy Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
Figure 5. Cell and Gene Therapy Market Share (%) - by Type (2023 and 2031)
Figure 6. Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Cell and Gene Therapy Market Share (%) - by Services (2023 and 2031)
Figure 9. Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Cell and Gene Therapy Market Share (%) - by Scale (2023 and 2031)
Figure 14. Pre-Commercial/R&D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Cell and Gene Therapy Market Share (%) - by Service Providers (2023 and 2031)
Figure 17. CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Cell and Gene Therapy Market Share (%) - by End User (2023 and 2031)
Figure 20. Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. South and Central America: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 25. Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 26. Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 27. Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 28. Growth Strategies in Cell and Gene Therapy Market